These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27855451)

  • 21. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.
    Lin HW; Chung CL; Lin YS; Yu CM; Lee CN; Bien MY
    PLoS One; 2015; 10(7):e0130102. PubMed ID: 26158649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J; Dik N; Bugden S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pragmatic approach to simplify inhaler therapy for COPD.
    Lipworth B; Jabbal S
    Lancet Respir Med; 2017 Sep; 5(9):679-681. PubMed ID: 28693987
    [No Abstract]   [Full Text] [Related]  

  • 24. Triple Therapy Is Also Effective in Real-World When Used in Chronic Obstructive Pulmonary Disease Patients Who Are Frequent Exacerbators.
    Cazzola M; Celli B
    Respiration; 2021; 100(2):93-95. PubMed ID: 33454710
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?
    Jones PW
    Am J Respir Crit Care Med; 2009 Oct; 180(8):689-90. PubMed ID: 19805796
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review.
    Riesco Miranda JA; Calle Rubio M; Díaz Pérez D; López-Campos JL; Trigueros Carrero JA; Celli B
    Arch Bronconeumol; 2024 Jan; 60(1):55-58. PubMed ID: 37985278
    [No Abstract]   [Full Text] [Related]  

  • 28. COPD drugs: the urgent need for innovation.
    Vestbo J; Lange P
    Lancet Respir Med; 2014 Jan; 2(1):14-5. PubMed ID: 24461887
    [No Abstract]   [Full Text] [Related]  

  • 29. Single vs Multiple Inhaler Triple Therapy in the COPD Population.
    Cho EE; Gershon AS
    Chest; 2022 Nov; 162(5):947-948. PubMed ID: 36344117
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan.
    Horita N; Kaneko T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():813-22. PubMed ID: 25960646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medical treatment of COPD].
    Vestbo J; Titlestad IL
    Ugeskr Laeger; 2013 Apr; 175(18):1261-4. PubMed ID: 23651802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of ICS/LABA on COPD treatment].
    Shibata Y
    Nihon Rinsho; 2016 May; 74(5):827-32. PubMed ID: 27254954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
    Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.
    Prakash A; Babu KS; Morjaria JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():111-23. PubMed ID: 25609944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some inhaled corticosteroids for COPD.
    Med Lett Drugs Ther; 2017 Apr; 59(1518):e66-e666. PubMed ID: 28377553
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA.
    Vos W; Hajian B; De Backer J; Van Holsbeke C; Vinchurkar S; Claes R; Hufkens A; Parizel PM; Bedert L; De Backer W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():263-71. PubMed ID: 26917956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward better COPD management: practical aspects of inhaler use.
    Garvey C; Ortiz G; Yawn BP
    Adv NPs PAs; 2011 Aug; 2(8):27-30, 32. PubMed ID: 21853640
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D.
    Anzueto A; Jenkins CR; Make BJ; Lindberg M; Calverley PM; Fagerås M; Postma DS; Rennard SI; Tashkin DP
    Eur Respir J; 2015 Jul; 46(1):255-8. PubMed ID: 26022947
    [No Abstract]   [Full Text] [Related]  

  • 39. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
    Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients.
    Porpodis K; Domvri K; Zarogoulidis P; Petridis D; Tsirgogianni K; Papaioannou A; Hatzizisi O; Kioumis I; Liaka A; Kikidaki V; Lampaki S; Organtzis J; Zarogoulidis K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1123-8. PubMed ID: 26109853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.